Nico H J Pijls Selected Research

Hyperemia

1/2020	Thermodilution-Based Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance: Quantification of Microvascular (Dys)Function?
10/2017	Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow Reserve.
4/2017	Saline-Induced Coronary Hyperemia: Mechanisms and Effects on Left Ventricular Function.
12/2016	The Influence of Lesion Location on the Diagnostic Accuracy of Adenosine-Free Coronary Pressure Wire Measurements.
4/2016	Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment.
7/2015	Fractional flow reserve, maximum hyperemia, adenosine, and regadenoson.
5/2015	Variability of fractional flow reserve according to the methods of hyperemia induction.
8/2013	Autoregulation of coronary blood flow in the isolated beating pig heart.
2/2006	Assessment of renal flow and flow reserve in humans.
12/2005	Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nico H J Pijls Research Topics

Disease

21	Pathologic Constriction (Stenosis) 12/2020 - 10/2004
20	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 04/2003
17	Myocardial Infarction 12/2021 - 12/2007
14	Hyperemia 01/2020 - 05/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 08/2005
9	ST Elevation Myocardial Infarction 08/2021 - 11/2011
7	Ischemia 12/2020 - 08/2005
7	Coronary Stenosis (Coronary Artery Stenosis) 10/2017 - 04/2003
5	Coronary Disease (Coronary Heart Disease) 09/2012 - 10/2007
4	Heart Failure 01/2021 - 06/2004
3	Thrombosis (Thrombus) 01/2021 - 03/2012
3	Infarction (Infarctions) 01/2021 - 12/2007
3	Death (Near-Death Experience) 01/2020 - 07/2017
3	Stable Angina 09/2013 - 11/2011
2	Hypothermia 02/2022 - 01/2021
2	Stroke (Strokes) 12/2021 - 03/2012
2	Reperfusion Injury 08/2021 - 12/2017
2	Myocardial Reperfusion Injury 01/2021 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 01/2020
2	Hemorrhage 01/2020 - 03/2012
2	Acute Coronary Syndrome 01/2020 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015 - 01/2012
2	Bundle-Branch Block (Fascicular Block) 11/2007 - 12/2005
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Hypertension (High Blood Pressure) 09/2013
1	Diabetes Mellitus 09/2013
1	Inflammation (Inflammations) 01/2012
1	Atherosclerosis 01/2012
1	Non-ST Elevated Myocardial Infarction 11/2011
1	Unstable Angina 11/2011
1	Renovascular Hypertension (Goldblatt Syndrome) 11/2006
1	Renal Artery Obstruction (Renal Artery Stenosis) 11/2006
1	Hyperplasia 11/2004
1	Cardiomyopathies (Cardiomyopathy) 06/2004
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2004

Drug/Important Bio-Agent (IBA)

15	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 05/2002
10	omega-Chloroacetophenone (Mace)IBA 12/2021 - 08/2005
4	MetalsIBA 08/2014 - 08/2006
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2012
2	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
2	regadenoson FDA Link 07/2015 - 05/2015
2	Adenosine Triphosphate (ATP)IBA 05/2015 - 04/2003
2	Sirolimus (Rapamycin)FDA Link 08/2014 - 08/2006
2	Abciximab (ReoPro)FDA Link 09/2013 - 03/2012
2	PapaverineIBA 08/2013 - 04/2003
2	Phenobarbital (Luminal)FDA Link 02/2008 - 12/2007
2	Phentolamine (Z-Max)FDA LinkGeneric 12/2005 - 11/2004
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	IceIBA 01/2021
1	von Willebrand FactorIBA 01/2020
1	titanium-nitride-oxideIBA 01/2020
1	Everolimus FDA Link 01/2020
1	ChromiumIBA 01/2020
1	PlatinumIBA 01/2020
1	PolymersIBA 01/2020
1	CobaltIBA 01/2020
1	Contrast MediaIBA 10/2017
1	Vasodilator Agents (Vasodilators)IBA 04/2016
1	Nicorandil (SG 75)IBA 05/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	CytokinesIBA 01/2012
1	Toll-Like Receptor 2IBA 01/2012
1	TroponinIBA 11/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2011
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 12/2010
1	ReninIBA 11/2006
1	Dopamine (Intropin)FDA LinkGeneric 02/2006
1	urapidilIBA 11/2004
1	alpha Adrenergic ReceptorsIBA 11/2004
1	antineoplaston A10 (A 10)IBA 10/2004
1	Iohexol (Omnipaque)FDA Link 04/2003

Therapy/Procedure

36	Percutaneous Coronary Intervention 08/2021 - 10/2004
18	Therapeutics 02/2022 - 12/2005
16	Stents 01/2021 - 06/2002
5	Drug-Eluting Stents 01/2019 - 07/2005
4	Catheters 04/2017 - 11/2006
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 10/2004
2	Counterpulsation (External Counterpulsation) 01/2020 - 07/2015
1	Transplantation 12/2021
1	Heart Transplantation (Grafting, Heart) 12/2021
1	Induced Hypothermia 12/2017
1	Length of Stay 11/2011
1	Cardiac Resynchronization Therapy 06/2004